Skip to main content
logo
CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.18684
+0.00034 (0.18%)
At close: Aug 10, 2026

CytoDyn Financials Overview

Millions USD. Fiscal year is Jun - May.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingFeb '26 May '25 May '24 May '23 May '22 May '21
Revenue
----0.27-
Revenue Growth
------
Gross Profit
----20.63-73.28-5.03
Operating Income
-21.429.66-18.06-40.58-145.4-94.55
Net Income
-40.282.26-51.32-86.74-212.45-178.15
Earnings Per Share
-0.040.00-0.05-0.10-0.31-0.30
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingFeb '26 May '25 May '24 May '23 May '22 May '21
Cash & Investments
15.6611.93.112.544.2333.94
Total Debt
28.8227.3430.0835.5536.863.47
Net Cash (Debt)
-13.16-15.44-26.97-33.01-32.57-29.53
Net Cash Growth
------
Net Cash Per Share
-0.01-0.01-0.03-0.04-0.05-0.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingFeb '26 May '25 May '24 May '23 May '22 May '21
Operating Cash Flow
-17.98-8.77-10.98-25.11-77.72-117.57
Capital Expenditures
------0.12
Free Cash Flow
-17.98-8.77-10.98-25.11-77.72-117.7
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingFeb '26 May '25 May '24 May '23 May '22 May '21
Operating Margin
-----54663.16%-
Pretax Margin
-----79255.64%-
Profit Margin
-----79867.67%-
FCF Margin
-----29219.17%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 May '25 May '24 May '23 May '22 May '21
PE Ratio
-188.79----
Forward PE
-10.1610.1610.1610.1610.16
PS Ratio
----867.10-